CTRI/2020/06/025789
Completed
未知
Role Of Very Low Dose Of Factor IX Prophylaxis In Severe Hemophilia B Patients
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Maulana Azad Medical College
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients with age greater than 13 years diagnosed as Severe Hemophilia B.
Exclusion Criteria
- •Patients with other bleeding disorders like Von Willebrands Disease
- •Patients with any liver disease or kidney disease
- •Patients on anticoagulation therapy
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Prophylactic Therapy In Hemophilia ACTRI/2020/07/026880Maulana Azad Medical College
Unknown
Not Applicable
A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing SurgeryHemophilia CNCT01538160Sheba Medical Center15
Active, not recruiting
Phase 1
Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia BHemophilia BNCT01687608Baxalta now part of Shire30
Recruiting
Not Applicable
The effect of recombinant Factor IX-FIAV in In-vitro thrombin generation in hemophilia A patient samplesNL-OMON47946Erasmus MC, Universitair Medisch Centrum Rotterdam21
Active, not recruiting
Phase 1
Study of a new medicinal factor IX product, IB1001, to treat patients with hemophilia BEUCTR2010-024190-39-GBAptevo Europe Limited22